The research points to specific clinical profiles where its mechanism addresses a genuine unmet need
These symptoms may include dizziness, difficulty walking normally, nervousness, anxiety, weakness, and uncoordinated movements
We are committed to providing our patients with innovative and science-based therapies to support healthy, sustainable weight loss and overall metabolic wellness
Patients who should not use CJC-1295/Ipamorelin include those with active malignancy or a personal history of hormone-sensitive cancer, patients with active acromegaly or pituitary pathology, and patients who are pregnant or breastfeeding
LG2055 has been found to help reduce visceral fat by ~8.5% over 12 weeks
One example is the Thymosin Alpha-1 peptide